NanoString analysis of neuroinflammation in multiple system atrophy by Kiely, AP et al.
A. P Kiely1, C. Murray1, Y.T Asi1, Z.  Ahmed1, T. Lashley1, T.  Revesz1, J.L Holton1 
1. Queen Square Brain Bank, Department of Molecular Neuroscience, UCL 
Institute of Neurology, London, UK 
a.kiely@ucl.ac.uk  
NanoString analysis of neuroinflammation in multiple system atrophy 
Introduction:Multiple system atrophy (MSA) is an adult-onset neurodegenerative 
disease characterised by aggregation of -synuclein in oligodendrocytes to form glial 
cytoplasmic inclusions (GCIs). We have previously demonstrated that microglial 
activation occurs in both severely affected regions of MSA brain and regions mildly 
affected, with few GCIs.  Showing that both pro-inflammatory (CD68 positive) and 
anti-inflammatory (Arginase-1 positive) microglia are present in both MSA and 
control brain. To obtain a more detailed view of the complex inflammatory 
environment of MSA, we investigated the gene expression profiles of 256 
inflammatory genes in post-mortem MSA brains. 
 
Materials and Methods: 
Patient brain donation enabled detailed post-mortem neuropathological examination 
and confirmed diagnosis of mixed MSA or control brain. Whole tissue was isolated 
from frontal cortex and cerebellar white matter of control (n=?) and MSA cases (N=6) 
and homogenised, total RNA was extracted using the Qiagen RNeasy kit and quality 
checked using an Eppendorf spectrophotometer. NanoString nCounter technology 
was used to analyse the levels or RNA associated with inflammation. Data analysis 
was performed using NanoString nSolver software. 
 
Results: 
Analysis of NanoString data has revealed a series of genes (n=286) which have 
significantly altered levels in MSA frontal cortex compared to control. Of particular 
note in the current study, three proinflammatory genes were upregulated while anti-
inflammatory genes were downregulated in MSA compared to control. 
 
Conclusion: 
Our work confirms that neuroinflammation is a feature of MSA and may be important 
in disease pathogenesis. Further investigations into the individual gene targets and their 
mechanisms of action in MSA pathogenesis are needed to identify their influence on the underlying 
disease mechanisms. These findings improve our understanding of this rare disease and 
may point to potential treatment strategies for MSA. 
 
